86 related articles for article (PubMed ID: 19815835)
1. Early cardiac iron overload in children with transfusion-dependent anemias.
Fernandes JL; Fabron A; Verissimo M
Haematologica; 2009 Dec; 94(12):1776-7. PubMed ID: 19815835
[No Abstract] [Full Text] [Related]
2. Iron chelation therapy for children with transfusion-dependent β-thalassemia: How young is too young?
Forni GL; Kattamis A; Kuo KHM; Maggio A; Sheth S; Taher AT; Viprakasit V
Pediatr Blood Cancer; 2024 Aug; 71(8):e31035. PubMed ID: 38753107
[TBL] [Abstract][Full Text] [Related]
3. Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload.
Smith GC; Alpendurada F; Carpenter JP; Alam MH; Berdoukas V; Karagiorga M; Ladis V; Piga A; Aessopos A; Gotsis ED; Tanner MA; Westwood MA; Galanello R; Roughton M; Pennell DJ
J Cardiovasc Magn Reson; 2011 Jul; 13(1):34. PubMed ID: 21733147
[TBL] [Abstract][Full Text] [Related]
4. Deferiprone versus deferoxamine for transfusional iron overload in sickle cell disease and other anemias: Pediatric subgroup analysis of the randomized, open-label FIRST study.
Hamdy M; El-Beshlawy A; Veríssimo MPA; Kanter J; Inusa B; Williams S; Lee D; Temin NT; Fradette C; Tricta F; Ebeid FSE; Kwiatkowski JL; Elalfy MS
Pediatr Blood Cancer; 2024 Jan; 71(1):e30711. PubMed ID: 37807937
[TBL] [Abstract][Full Text] [Related]
5. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance.
Modell B; Khan M; Darlison M; Westwood MA; Ingram D; Pennell DJ
J Cardiovasc Magn Reson; 2008 Sep; 10(1):42. PubMed ID: 18817553
[TBL] [Abstract][Full Text] [Related]
6. How I treat non-transfusion-dependent β-thalassemia.
Saliba AN; Musallam KM; Taher AT
Blood; 2023 Sep; 142(11):949-960. PubMed ID: 37478396
[TBL] [Abstract][Full Text] [Related]
7. β-thalassemia intermedia: a clinical perspective.
Musallam KM; Taher AT; Rachmilewitz EA
Cold Spring Harb Perspect Med; 2012 Jul; 2(7):a013482. PubMed ID: 22762026
[TBL] [Abstract][Full Text] [Related]
8. Growth and endocrinopathies among children with β-Thalassemia major treated at Dubai Thalassemia centre.
Almahmoud R; Hussein A; Khaja FA; Soliman AF; Dewedar H; Shareef ZA; Mathai S
BMC Pediatr; 2024 Apr; 24(1):244. PubMed ID: 38580952
[TBL] [Abstract][Full Text] [Related]
9. Use of magnetic resonance imaging to monitor iron overload.
Wood JC
Hematol Oncol Clin North Am; 2014 Aug; 28(4):747-64, vii. PubMed ID: 25064711
[TBL] [Abstract][Full Text] [Related]
10. A Systematic Review and Meta-Analysis of Stature Growth Complications in β-thalassemia Major Patients.
Arab-Zozani M; Kheyrandish S; Rastgar A; Miri-Moghaddam E
Ann Glob Health; 2021 Jun; 87(1):48. PubMed ID: 34164261
[TBL] [Abstract][Full Text] [Related]
11. Physiology and pathophysiology of iron in hemoglobin-associated diseases.
Coates TD
Free Radic Biol Med; 2014 Jul; 72():23-40. PubMed ID: 24726864
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias.
Shah FT; Porter JB; Sadasivam N; Kaya B; Moon JC; Velangi M; Ako E; Pancham S
Br J Haematol; 2022 Jan; 196(2):336-350. PubMed ID: 34617272
[No Abstract] [Full Text] [Related]
13. Iron overload cardiomyopathy: better understanding of an increasing disorder.
Gujja P; Rosing DR; Tripodi DJ; Shizukuda Y
J Am Coll Cardiol; 2010 Sep; 56(13):1001-12. PubMed ID: 20846597
[TBL] [Abstract][Full Text] [Related]
14. The growing child with thalassaemia.
Skordis N
J Pediatr Endocrinol Metab; 2006 Apr; 19(4):467-9. PubMed ID: 16759031
[No Abstract] [Full Text] [Related]
15. The Role of Deferiprone in Iron Chelation.
Gallie BL; Olivieri NF
N Engl J Med; 2019 Feb; 380(9):892. PubMed ID: 30811926
[No Abstract] [Full Text] [Related]
16. Compliance and clinical benefit of deferasirox granule and dispersible tablet formulation in pediatric patients with transfusional iron overload: in a randomized, open-label, multicenter, phase II study.
Taher AT; Wali Y; Cruz MC; Charoenkwan P; Aydinok Y; Werner O; Govindaraju S; Romen F; Viprakasit V
Haematologica; 2024 May; 109(5):1413-1425. PubMed ID: 37855069
[TBL] [Abstract][Full Text] [Related]
17. Cardiac MRI for Iron Overload in pediatric thalassemia patients- Right Age to Start in a Resource Constrained Environment.
Pilania K; Jankharia B; Kazi A
Indian J Hematol Blood Transfus; 2022 Jul; 38(3):566-570. PubMed ID: 35747577
[TBL] [Abstract][Full Text] [Related]
18. Correlation between Myocardial Iron Overload Detected by CMRT2* and Left Ventricular Function Assessed by Tissue Doppler Imaging in Patients with Thalassemia Major.
Najimi M; Ghandi Y; Mehrabi S; Eghbali A; Habibi D
J Cardiovasc Echogr; 2022; 32(1):17-22. PubMed ID: 35669139
[TBL] [Abstract][Full Text] [Related]
19. Cardiac T
Triadyaksa P; Oudkerk M; Sijens PE
J Magn Reson Imaging; 2020 Nov; 52(5):1340-1351. PubMed ID: 31837078
[TBL] [Abstract][Full Text] [Related]
20. Early detection of myocardial dysfunction in poorly treated pediatric thalassemia children and adolescents: Two Saudi centers experience.
Ibrahim MH; Azab AA; Kamal NM; Salama MA; Ebrahim SA; Shahin AM; El-Sadek AE; Abdulghany WE; Sherief LM; Abdallah EA
Ann Med Surg (Lond); 2016 Aug; 9():6-11. PubMed ID: 27330742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
